Imeik Technology Development Co Ltd
SZSE:300896
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
134.05
282.72
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Imeik Technology Development Co Ltd
Imeik Technology Development Co Ltd
Operating Income
Imeik Technology Development Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Income
¥2.1B
|
CAGR 3-Years
64%
|
CAGR 5-Years
71%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Operating Income
-¥8.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Income
-¥1.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Operating Income
¥2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Income
¥4.3B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
11%
|
CAGR 10-Years
42%
|
|
Imeik Technology Development Co Ltd
Glance View
Imeik Technology Development Co Ltd is a prominent player in the cosmetic medical industry, a sector that has experienced robust growth fueled by rising consumer demand for aesthetic enhancements. Situated in the heart of the beauty-conscious market of China, Imeik specializes in the development, manufacturing, and commercialization of medical aesthetic products, most notably hyaluronic acid fillers. These products, used extensively by dermatologists and beauty clinics, cater to individuals seeking non-invasive procedures to enhance their aesthetic appeal. By leveraging advanced biotechnological methodologies, Imeik has positioned itself as a trusted brand, gaining an edge through continual innovation and adherence to rigorous safety standards. The company's business model revolves around the strategic development and distribution of a diversified portfolio of aesthetic products. Imeik's revenue streams principally derive from the commercialization of its cutting-edge dermal fillers and other complementary medical solutions. By focusing on research and development, the company not only stays ahead of aesthetic trends but also ensures that its offerings maintain a high standard of efficacy and safety, essential in a sensitive market domain like medical aesthetics. Furthermore, Imeik’s collaborations with key stakeholders in the healthcare and cosmetic sectors amplify its reach, solidifying its market position and driving sustainable profitability. Through these endeavors, Imeik effectively captures a slice of the lucrative and rapidly growing beauty market, reinforcing its leadership within the industry.
See Also
What is Imeik Technology Development Co Ltd's Operating Income?
Operating Income
2.1B
CNY
Based on the financial report for Dec 31, 2023, Imeik Technology Development Co Ltd's Operating Income amounts to 2.1B CNY.
What is Imeik Technology Development Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
71%
Over the last year, the Operating Income growth was 51%. The average annual Operating Income growth rates for Imeik Technology Development Co Ltd have been 64% over the past three years , 71% over the past five years .
You don't have any saved screeners yet
